SHPH
HEALTHCAREShuttle Pharmaceuticals Inc
AI Insight
What's Moving SHPH Today?
No stock-specific AI insight has been generated for SHPH yet. Check back soon — insights are generated from recent news analysis.
Market Briefings featuring SHPH
52-Week Range
$3.16$55.90
$3.92
Fundamentals
Market Cap$2M
P/E Ratio35.2
EPS$0.10
Dividend Yield—
Dividend / Share—
ROE-326.4%
Profit Margin—
Debt / Equity—
Trading
Volume45K
Avg Volume (10D)—
Shares Outstanding585K
SHPH News
17 articles- Shuttle to Acquire United Dogecoin in Push to Build Public DOGE Mining PlatformCryptoprowl·May 1, 2026
- RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific WorkflowsYahoo Finance·Mar 27, 2026
- Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific WorkflowsYahoo Finance·Mar 26, 2026
- E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals’ $3.5 Million Public OfferingYahoo Finance·Mar 12, 2026
- Shuttle Pharmaceuticals Announces $3.5 Million Public OfferingYahoo Finance·Mar 6, 2026
- Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than EverYahoo Finance·Jan 13, 2026
- Shuttle Pharma Layers AI Into Its Big Oncology PushMoby·Dec 18, 2025
- Shuttle Pharmaceuticals Acquires AI Health PlatformYahoo Finance·Nov 21, 2025
- Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00Yahoo Finance·Nov 3, 2025
- Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)Yahoo Finance·Oct 22, 2025
- Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)Yahoo Finance·Oct 22, 2025
- Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)Yahoo Finance·Oct 21, 2025
- Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics PlatformYahoo Finance·Oct 21, 2025
- Shuttle Executes LOI with Molecule.aiYahoo Finance·Oct 10, 2025
- Shuttle to Enter $3.24 Billion AI Pharmaceutical MarketYahoo Finance·Oct 9, 2025
- Shuttle Pharma Provides Second Quarter 2025 Corporate UpdateYahoo Finance·Aug 14, 2025
- Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-MarketYahoo Finance·Jun 24, 2025
All 17 articles loaded
Price Data
Open$3.45
Previous Close$3.52
Day High$3.92
Day Low$3.43
52 Week High$55.90
52 Week Low$3.16
52-Week Range
$3.16$55.90
$3.92
Fundamentals
Market Cap$2M
P/E Ratio35.2
EPS$0.10
Dividend Yield—
Dividend / Share—
ROE-326.4%
Profit Margin—
Debt / Equity—
Trading
Volume45K
Avg Volume (10D)—
Shares Outstanding585K
About Shuttle Pharmaceuticals Inc
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of drugs to sensitize cancers to radiation therapy. The company is headquartered in Rockville, Maryland.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—